All In MedTech

Device Trial Radar · NCT02871258

MetaNeb® Chest X-ray Study

Evaluation of The MetaNeb® System to Reduce Atelectasis Assessed by Chest X-ray

Last checked: Nov 20, 2026Latest source record: Sep 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

8

Actual

Start

Sep 2016

Primary completion

Aug 17, 2017

Study completion Aug 17, 2017

Sponsor

Lead sponsor
Hill-RomNot on our public-company list
Sponsor type
Industry
First posted
Aug 18, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To study objective is to evaluate the impact of use of The MetaNeb® System in clearance of atelectasis, as demonstrated by improvement in chest x-rays. This is a a non-randomized open label study, with all subjects receiving treatment with The MetaNeb® System. Subjects who qualify for enrollment in the study will receive therapy with The MetaNeb® System following the labeled instructions for the device. Details of the treatment including duration and frequency will be defined in treatment procedures.

Conditions

  • Atelectasis

Interventions

  • The MetaNeb® SystemDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Chest X-ray Score at Day 2 (Approximately 48 Hours) After Initiation of Therapy With The MetaNeb® System.Time frame: Approximately 48 hours post-initiation of therapy with The MetaNeb® System.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.